Share-based Payment Arrangement, Expense in USD of SQZ Biotechnologies Co from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SQZ Biotechnologies Co quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2019 to Q3 2023.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2023 was $983K, a 58.6% decline year-over-year.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2023 was $4.6M, a 48.5% decline year-over-year.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2022 was $8.4M, a 1.2% decline from 2021.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2021 was $8.51M, a 136% increase from 2020.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2020 was $3.6M, a 70.9% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

SQZ Biotechnologies Co Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $4.6M $983K -$1.39M -58.6% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $6M $1.15M -$1.16M -50.1% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $7.15M $695K -$1.25M -64.3% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $8.4M $1.77M -$541K -23.4% 01 Oct 2022 31 Dec 2022 10-K 22 Mar 2023
Q3 2022 $8.94M $2.38M -$405K -14.6% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $9.35M $2.31M +$478K +26.1% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $8.87M $1.95M +$366K +23.2% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $8.51M $2.31M +$960K +70.9% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $7.55M $2.78M +$1.99M +249% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $5.56M $1.83M +$1.08M +143% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $4.49M $1.58M +$883K +127% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $3.6M $1.35M 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 $796K +$305K +62.1% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $754K 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $698K 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q3 2019 $491K 01 Jul 2019 30 Sep 2019 10-Q 10 Dec 2020

SQZ Biotechnologies Co Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $8.4M -$102K -1.2% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2023
2021 $8.51M +$4.9M +136% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 $3.6M +$1.49M +70.9% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 $2.11M 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.